Drw Securities, LLC Macrogenics Inc Transaction History

Drw Securities, LLC

$4.23 Billion
Q2 2025

A detailed history of Drw Securities, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Drw Securities, LLC holds 18,196 shares of MGNX stock, worth $31,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,196

Holding current value

$31,661

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$1.06 - $1.79 $19,287 - $32,570	18,196 New	18,196 $22,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $43,377 - $242,573	13,105 New	13,105 $55,000

Others Institutions Holding MGNX

# of Institutions

119

Shares Held

52.3M

Call Options Held

55.3K

Put Options Held

35.9K

Bellevue Group Ag Kuesnacht, V8

9.92M
Shares

$17.3 Million
0.27% of portfolio
Armistice Capital, LLC New York, NY

5.96M
Shares

$10.4 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$9.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.21M
Shares

$7.33 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.25M
Shares

$5.66 Million
0.02% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $107M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.

Account